Sanofi Can't Nix Shareholder Suit Over Zimulti

Law360, New York (March 30, 2011, 7:10 PM EDT) -- A New York federal judge on Wednesday largely denied Sanofi-Aventis SA's bid to toss a putative securities class action accusing the French pharmaceutical giant of withholding information from investors concerning anti-obesity drug Zimulti's tendency to cause severe psychiatric problems.

Judge George Daniels of the U.S. District Court for the Southern District of New York granted the defendants' motion to dismiss with respect to Sanofi CEO Jean-Francois Dehecq and executives Marc Cluzel, Jean-Pierre Lehner, Douglas A. Greene and Jean-Claude Leroy, but kept Sanofi itself and two other...
To view the full article, register now.




Case Information

Case Title

Smith v. Sanofi-Aventis et al

Case Number



New York Southern

Nature of Suit



George B. Daniels

Date Filed

January 1, 2008

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.